Clinical Trials
4
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH
Phase 1
Not yet recruiting
- Conditions
- Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-06-11
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Changchun Intellicrown Pharmaceutical Co. LTD
- Target Recruit Count
- 40
- Registration Number
- NCT07016633
- Locations
- 🇨🇳
The first Bethune hospital of Jilin University, Changchun, Jilin, China
To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects
Phase 1
Recruiting
- Conditions
- Nonalcoholic Steatohepatitis (NASH)
- Interventions
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Changchun Intellicrown Pharmaceutical Co. LTD
- Target Recruit Count
- 138
- Registration Number
- NCT06216041
- Locations
- 🇨🇳
The first Bethune hospital of Jilin University, Changchun, Jilin, China
ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies
- First Posted Date
- 2020-06-02
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Changchun Intellicrown Pharmaceutical Co. LTD
- Target Recruit Count
- 60
- Registration Number
- NCT04412616
- Locations
- 🇨🇳
The first Bethune hospital of Jilin University, Changchun, Jilin, China
🇺🇸Cedars Sinai Medical Center, Los Angeles, California, United States
🇺🇸Kansas University Cancer Center, Fairway, Kansas, United States
Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumors
- First Posted Date
- 2019-10-15
- Last Posted Date
- 2023-09-01
- Lead Sponsor
- Changchun Intellicrown Pharmaceutical Co. LTD
- Target Recruit Count
- 39
- Registration Number
- NCT04126590
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
News
No news found